Search research articles
Contact Us
Filters
Showing results (81-90 of 193) with videos related to
Page
of 20
Sort By:
Scientific Reports
|
November 16, 2024
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis
Elsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Medicina (Kaunas, Lithuania)
|
June 27, 2025
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel
Hakan Taban, Mustafa Erman, Deniz Can Guven, et al.
Expert Review of Molecular Diagnostics
|
February 26, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors
Taha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Journal of Immunotherapy and Precision Oncology
|
December 25, 2023
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, et al.
Irish Journal of Medical Science
|
May 9, 2020
Cancer incidence in Behçet's disease
Deniz Can Guven, Ertugrul Cagri Bolek, Sabri Engin Altintop, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|
July 10, 2025
Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy
Elvin Chalabıyev, Rashad Ismayılov, Fatih Kus, et al.
Expert Review of Anticancer Therapy
|
February 24, 2025
Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors
Onur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, et al.
Turkish Journal of Medical Sciences
|
November 24, 2022
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
Fatih Gürler, Deniz Can Güven, Ergin Aydemir, et al.
Expert Review of Anticancer Therapy
|
January 8, 2025
The association between HALP score and survival in patients treated with immune checkpoint inhibitors
Taha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
International Journal of Clinical Oncology
|
October 18, 2021
HER2-low breast cancer could be associated with an increased risk of brain metastasis
Deniz Can Guven, Mehmet Burak Kaya, Burak Fedai, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 193) with videos related to
Sort By:
Page
of 20
Scientific Reports
|
November 16, 2024
Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis
Elsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Medicina (Kaunas, Lithuania)
|
June 27, 2025
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel
Hakan Taban, Mustafa Erman, Deniz Can Guven, et al.
Expert Review of Molecular Diagnostics
|
February 26, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors
Taha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
Journal of Immunotherapy and Precision Oncology
|
December 25, 2023
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab
Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, et al.
Irish Journal of Medical Science
|
May 9, 2020
Cancer incidence in Behçet's disease
Deniz Can Guven, Ertugrul Cagri Bolek, Sabri Engin Altintop, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|
July 10, 2025
Prognostic and predictive significance of the pan-immune-inflammation value in endometrial cancer patients undergoing adjuvant therapy
Elvin Chalabıyev, Rashad Ismayılov, Fatih Kus, et al.
Expert Review of Anticancer Therapy
|
February 24, 2025
Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors
Onur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, et al.
Turkish Journal of Medical Sciences
|
November 24, 2022
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
Fatih Gürler, Deniz Can Güven, Ergin Aydemir, et al.
Expert Review of Anticancer Therapy
|
January 8, 2025
The association between HALP score and survival in patients treated with immune checkpoint inhibitors
Taha Koray Sahin, Deniz Can Guven, Mert Durukan, et al.
International Journal of Clinical Oncology
|
October 18, 2021
HER2-low breast cancer could be associated with an increased risk of brain metastasis
Deniz Can Guven, Mehmet Burak Kaya, Burak Fedai, et al.
Page
of 20